Life sciences' leading M&A deals worldwide H1 2018

Published by Statista Research Department, Sep 24, 2019
The statistic depicts the leading merger and acquisition deals in the life sciences industry worldwide in the first half of 2018. In the period examined, Bayer's acquisition of Monsanto was the largest M&A deal, with a value of approximately 63 billion U.S. dollars.

Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2018

Region

Worldwide

Survey time period

January to June 2018

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology industry in Germany Global pharmaceutical industryBiotech drugs
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu